A patient enrolled in Ziopharm Oncology Inc.'s (Nasdaq: ZIOP) study of its experimental gene therapy to treat brain cancer has died. The stock price dropped 66 cents to close at $5.01.
Patient in Ziopharm Oncology study died
July 15, 2016 at 19:29 PM EDT
